EPGNY

Epigenomics AG

 
Sponsored ADR (1 ADS : 5 Ordinary) International Reporting
OTCQX International OTCQX Advisor: BNY Mellon
Verified Company Profile 11/10/2017
Contact Info
  • GeneststraBe 5
  • Berlin D-10829
  • Germany

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: Frankfurt Stock Exchange
Audited Financials Audited
Latest Report Jun 30, 2017 Semi-Annual Report
CIK 0001580128
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2835 - Diagnostic substances
Incorporated In: Germany
Year of Inc. 1998
Employees 45 a/o Dec 31, 2016
Company Officers/Contacts
Heino von Prondzynski Chairman of the Supervisory Board
Gregory Hamilton CEO
Dr. Uwe Staub COO
Peter Vogt VP, Corp. Comm., IR
Company Directors
Ann Clare Kessler, Ph.D.
Prof. Gunther Reiter
Company Notes
  • Sponsored for OTCQX by BNY Mellon on 01/10/2014
Service Providers
OTCQX Advisor
BNY Mellon
101 Barclay Street
22nd Floor
New York, NY, 10286
USA

Accounting/Auditing Firm
Baker Tilly Virchow Krause, LLP
225 South 6th Street
Suite 2300
Minneapolis, MN, 55402
United States

Legal Counsel
Hengeler Mueller
Behrenstrasse 42
Berlin, 10117
Germany

Behrenstrass'e
Investor Relations Firm
Not Available
EPGNY Security Details Other Company Securities
Share Structure
Market Value1 $116,277,531 a/o Nov 16, 2017
Authorized Shares Not Available
Outstanding Shares 24,014,360 a/o Oct 12, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
BNY Mellon
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
ECX - Frankfurt Stock Exchange - Qualified
Short Selling Data
Short Interest 10 (0%)
Oct 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security